# Cohen & Steers, Inc.: overview

CNS · NYSE · CIK 1284812 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cns.md) · [Financials](/companies/cns/financials.md) · [Filings](/companies/cns/filings.md) · [Insiders](/companies/cns/insiders.md)

Latest reported revenue: [$157.4m](/filings/0001284812-26-000200.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 30, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001284812-26-000200).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [140 d](/filings/0001284812-26-000011.md) | [134](/filings/0001284812-26-000045.md) | [136](/filings/0001284812-26-000146.md) | [142](/filings/0001284812-26-000200.md) | [144 d](/filings/0001284812-26-000011.md) | [146](/filings/0001284812-26-000045.md) | [153](/filings/0001284812-26-000146.md) | [157](/filings/0001284812-26-000200.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [35.3% d](/filings/0001284812-26-000011.md) | [33.6%](/filings/0001284812-26-000045.md) | [31.8%](/filings/0001284812-26-000146.md) | [34.5%](/filings/0001284812-26-000200.md) | [28.0% d](/filings/0001284812-26-000011.md) | [34.4%](/filings/0001284812-26-000045.md) | [34.6%](/filings/0001284812-26-000146.md) | [32.4%](/filings/0001284812-26-000200.md) |
| Net margin | % | [32.8% d](/filings/0001284812-26-000011.md) | [29.6%](/filings/0001284812-26-000045.md) | [27.1%](/filings/0001284812-26-000146.md) | [29.4%](/filings/0001284812-26-000200.md) | [24.3% d](/filings/0001284812-26-000011.md) | [29.1%](/filings/0001284812-26-000045.md) | [32.3%](/filings/0001284812-26-000146.md) | [26.8%](/filings/0001284812-26-000200.md) |
| Diluted EPS | $ per share | not reported | [0.77](/filings/0001284812-26-000045.md) | [0.72](/filings/0001284812-26-000146.md) | [0.81](/filings/0001284812-26-000200.md) | not reported | [0.82](/filings/0001284812-26-000045.md) | [0.95](/filings/0001284812-26-000146.md) | [0.81](/filings/0001284812-26-000200.md) |
| Free cash flow | $m | [33.1 d](/filings/0001284812-26-000011.md) | [(110)](/filings/0001284812-26-000045.md) | [(69.8) d](/filings/0001284812-26-000146.md) | [52.6 d](/filings/0001284812-26-000200.md) | [0.8 d](/filings/0001284812-26-000011.md) | not reported | not reported | [20.0 d](/filings/0001284812-26-000200.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [584](/filings/0001284812-24-000139.md) | [567](/filings/0001284812-25-000087.md) | [490](/filings/0001284812-26-000011.md) | [517](/filings/0001284812-26-000011.md) | [556](/filings/0001284812-26-000011.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [44.6%](/filings/0001284812-24-000139.md) | [38.1%](/filings/0001284812-25-000087.md) | [33.6%](/filings/0001284812-26-000011.md) | [33.4%](/filings/0001284812-26-000011.md) | [32.0%](/filings/0001284812-26-000011.md) |
| Net margin | % | [36.2%](/filings/0001284812-24-000139.md) | [30.2%](/filings/0001284812-25-000087.md) | [26.4%](/filings/0001284812-26-000011.md) | [29.2%](/filings/0001284812-26-000011.md) | [27.6%](/filings/0001284812-26-000011.md) |
| Diluted EPS | $ per share | [4.31](/filings/0001284812-24-000139.md) | [3.47](/filings/0001284812-25-000087.md) | [2.60](/filings/0001284812-26-000011.md) | [2.97](/filings/0001284812-26-000011.md) | [2.97](/filings/0001284812-26-000011.md) |
| Free cash flow | $m | [240](/filings/0001284812-24-000139.md) | [57.5](/filings/0001284812-25-000087.md) | [115](/filings/0001284812-26-000011.md) | [85.0](/filings/0001284812-26-000011.md) | [(126)](/filings/0001284812-26-000011.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cns/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $343.4m | 4,509,985 |  | Added +125,980 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $129.6m | 1,701,955 |  | Added +50,891 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $96.0m | 1,261,258 |  | Added +3,796 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $91.3m | 1,198,753 |  | Added +24,174 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $90.8m | 1,192,323 |  | Added +43,762 |
| [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $90.3m | 1,185,911 |  | Reduced −911,598 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $81.0m | 1,064,399 |  | Added +97,383 |
| [VICTORY CAPITAL MANAGEMENT INC](/funds/1040188.md) | 2026-06-30 | $73.3m | 962,591 |  | Added +277,642 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $70.4m | 923,968 |  | Added +102,790 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $67.5m | 885,879 |  | Added +76,434 |

## Recent filings

[All 1,960 filings](/companies/cns/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 08:49 ET | [10-Q](/filings/0001284812-26-000200.md) | Quarterly report, period 2026-09-30 | 0001284812-26-000200 |
| 2026-10-15 | 16:24 ET | [8-K](/filings/0001284812-26-000195.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001284812-26-000195 |
| 2026-07-31 | 08:34 ET | [10-Q](/filings/0001284812-26-000146.md) | Quarterly report, period 2026-06-30 | 0001284812-26-000146 |
| 2026-07-16 | 16:40 ET | [8-K](/filings/0001284812-26-000142.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001284812-26-000142 |
| 2026-05-21 | 16:34 ET | [8-K](/filings/0001193125-26-234594.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-234594 |
| 2026-05-04 | 16:18 ET | [8-K](/filings/0001284812-26-000049.md) | 5.07 Shareholder vote results | 0001284812-26-000049 |
| 2026-05-01 | 08:34 ET | [10-Q](/filings/0001284812-26-000045.md) | Quarterly report, period 2026-03-31 | 0001284812-26-000045 |
| 2026-04-16 | 16:25 ET | [8-K](/filings/0001284812-26-000035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001284812-26-000035 |
| 2026-03-20 | 09:07 ET | [DEF 14A](/filings/0001284812-26-000030.md) | Proxy statement, period 2026-04-30 | 0001284812-26-000030 |
| 2026-02-27 | 08:49 ET | [10-K](/filings/0001284812-26-000011.md) | Annual report, period 2025-12-31 | 0001284812-26-000011 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001284812-26-000011.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1284812
- Tickers: CNS
- Exchange: NYSE
- SIC code: 6282 Investment Advice
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 31, 2026, 03:21 ET. No prices; not investment advice.